Acetazolamide-related hypophosphatemia leading to cardiac arrest is extremely rare. Herein we report a 78-year-old female glaucoma patient who developed general weakness and acute respiratory failure, ...
Please provide your email address to receive an email when new articles are posted on . BIG FLATS, N.Y. — X-GEN Pharmaceuticals will begin marketing acetazolamide for injection, the equivalent of ...
To determine whether the 1-day postoperative intraocular pressure (IOP) check following routine uncomplicated phacoemulsification is necessary in patients with pre-existing glaucoma and ocular ...
To determine the effect of oral acetazolamide on lowering the peak and duration of intraocular pressure (IOP) rise in glaucoma and glaucoma suspect patients, following intravitreal injection of ...
Background This is a 63-year-old female hiker with normal corrected vision followed status post emergent surgery secondary to bilateral acute angle closure glaucoma (AACG). She was started on ...
New Delhi, Apr 6 (PTI) Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture and market its generic Acetazolamide tablets used in the ...
Please provide your email address to receive an email when new articles are posted on . Studies show that lowering intraocular pressure (IOP) reduces the rate of progression of glaucoma. First-line ...
J Glaucoma. 2015;24(4):E31-e33. In our case, the patient presented with typical features of hypophosphatemia including general weakness, hypercapnic respiratory failure, arrhythmias, and cardiac ...
Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture and market its generic Acetazolamide tablets used in the treatment of glaucoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results